Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gallagher

Showing results (641-650 of 672) with videos related to

Pageof 68
Sort By:
Pediatrics|September 5, 2023
Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and SafetyJaime Restrepo, Teobaldo Herrera, Rudiwilai Samakoses, et al.
Acta Haematologica|September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic LeukemiaMuhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Vaccine|January 7, 2026
Determining the dose-response relationship for pneumococcal conjugate vaccines: a nested analysis of the fractional dose PCV trialIrene Martinez-de-Albeniz, Christian Bottomley, Ruth Lucinde, et al.
Blood|August 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trialSylvie D Freeman, Abin Thomas, Ian Thomas, et al.
Blood|June 27, 2012
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemiaRobert E Gallagher, Barry K Moser, Janis Racevskis, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imagingBetty B Yao, Gin Hsieh, Anthony V Daza, et al.
Plos One|June 2, 2023
The impact of the COVID-19 pandemic on the provision & utilisation of primary health care services in Goma, Democratic Republic of the Congo, Kambia district, Sierra Leone & Masaka district, UgandaK Kasonia, D Tindanbil, J Kitonsa, et al.
International Dental Journal|February 22, 2021
Developing a Standard Set of Patient-centred Outcomes for Adult Oral Health - An International, Cross-disciplinary ConsensusRicheal Ni Riordain, Michael Glick, Shiamaa Shihab Ahmed Al Mashhadani, et al.
Nature Medicine|September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphomaNicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Evolution, Medicine, and Public Health|February 27, 2020
Evolutionary consequences of feedbacks between within-host competition and disease controlMegan A Greischar, Helen K Alexander, Farrah Bashey, et al.
Pageof 68

Showing results (641-650 of 672) with videos related to

Sort By:
Pageof 68
Pediatrics|September 5, 2023
Ten-Year Follow-up of 9-Valent Human Papillomavirus Vaccine: Immunogenicity, Effectiveness, and SafetyJaime Restrepo, Teobaldo Herrera, Rudiwilai Samakoses, et al.
Acta Haematologica|September 16, 2016
Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic LeukemiaMuhamed Baljevic, Bogdan Dumitriu, Ju-Whei Lee, et al.
Vaccine|January 7, 2026
Determining the dose-response relationship for pneumococcal conjugate vaccines: a nested analysis of the fractional dose PCV trialIrene Martinez-de-Albeniz, Christian Bottomley, Ruth Lucinde, et al.
Blood|August 18, 2023
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trialSylvie D Freeman, Abin Thomas, Ian Thomas, et al.
Blood|June 27, 2012
Treatment-influenced associations of PML-RARα mutations, FLT3 mutations, and additional chromosome abnormalities in relapsed acute promyelocytic leukemiaRobert E Gallagher, Barry K Moser, Janis Racevskis, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 22, 2008
Characterization of a cannabinoid CB2 receptor-selective agonist, A-836339 [2,2,3,3-tetramethyl-cyclopropanecarboxylic acid [3-(2-methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], using in vitro pharmacological assays, in vivo pain models, and pharmacological magnetic resonance imagingBetty B Yao, Gin Hsieh, Anthony V Daza, et al.
Plos One|June 2, 2023
The impact of the COVID-19 pandemic on the provision & utilisation of primary health care services in Goma, Democratic Republic of the Congo, Kambia district, Sierra Leone & Masaka district, UgandaK Kasonia, D Tindanbil, J Kitonsa, et al.
International Dental Journal|February 22, 2021
Developing a Standard Set of Patient-centred Outcomes for Adult Oral Health - An International, Cross-disciplinary ConsensusRicheal Ni Riordain, Michael Glick, Shiamaa Shihab Ahmed Al Mashhadani, et al.
Nature Medicine|September 13, 2022
Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphomaNicholas J Haradhvala, Mark B Leick, Katie Maurer, et al.
Evolution, Medicine, and Public Health|February 27, 2020
Evolutionary consequences of feedbacks between within-host competition and disease controlMegan A Greischar, Helen K Alexander, Farrah Bashey, et al.
Pageof 68